Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxygen-Ozone and Probiotics in COVID-19
NCT04366089Phase 2Unknown
- Start
- Mar 2020
- Primary completion
- Oct 2020
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (2 arms). Primary endpoint: Delta in the number of patients requiring orotracheal intubation despite treatment at 21 days. Status: unknown.
Beyond the preview
Go deeper on NCT04366089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04366089.